— Know what they know.
Not Investment Advice
Also trades as: 0Y6X.L (LSE) · $vol 1M · 2M6.DE (XETRA) · $vol 0M

MDT NYSE

Medtronic plc
1W: +1.5% 1M: -6.1% 3M: -19.3% YTD: -18.6% 1Y: -8.1% 3Y: -4.6% 5Y: -28.4%
$78.60
+0.45 (+0.58%)
 
Weekly Expected Move ±3.8%
$70 $73 $76 $79 $82
NYSE · Healthcare · Medical - Devices · Alpha Radar Sell · Power 42 · $100.9B mcap · 1.28B float · 0.686% daily turnover · Short 19% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
33.5 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 7.7%  ·  5Y Avg: 6.7%
Cost Advantage
30
Intangibles
14
Switching Cost
12
Network Effect
55
Scale ★
85
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. MDT has No discernible competitive edge (33.5/100). The business operates without significant structural advantages. The primary source of advantage is Efficient Scale. ROIC of 7.7% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$84
Low
$106
Avg Target
$120
High
Based on 9 analysts since Feb 17, 2026 earnings
Analyst Recommendations
Strong Buy: 1Buy: 26Hold: 22Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$105.57
Analysts7
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-21 Goldman Sachs $111 $84 -27 +7.5% $78.15
2026-04-23 Jefferies Matthew Taylor $110 $95 -15 +13.4% $83.79
2026-04-15 Truist Financial Richard Newitter $107 $95 -12 +9.3% $86.88
2026-04-13 Mizuho Securities $98 $120 +22 +38.3% $86.75
2026-04-09 Evercore ISI Vijay Kumar $104 $106 +2 +20.6% $87.91
2026-03-10 Leerink Partners Mike Kratky $120 $119 -1 +31.8% $90.31
2026-03-10 Needham Michael Matson $121 $120 -1 +33.0% $90.21
2026-02-18 Robert W. Baird $103 $100 -3 +3.7% $96.41
2026-02-18 Barclays Matt Miksic $116 $118 +2 +22.4% $96.41
2026-02-09 Needham $124 $121 -3 +17.6% $102.90
2026-02-04 UBS $135 $104 -31 +0.6% $103.38
2026-01-30 Wells Fargo Larry Biegelsen $106 $114 +8 +12.0% $101.78
2026-01-09 Bernstein $111 $112 +1 +13.5% $98.69
2026-01-08 Barclays Matt Miksic $111 $116 +5 +16.3% $99.77
2025-12-18 Truist Financial Richard Newitter $103 $107 +4 +7.9% $99.14
2025-12-16 Robert W. Baird $96 $103 +7 +4.4% $98.67
2025-11-20 Barclays $85 $111 +26 +10.6% $100.34
2025-11-19 Bernstein Lee Hambright $98 $111 +13 +10.6% $100.34
2025-11-19 Leerink Partners Mike Kratky Initiated $120 +19.0% $100.80
2025-11-19 Jefferies Matthew Taylor $155 $110 -45 +9.1% $100.80
2025-11-19 Goldman Sachs David Roman $82 $111 +29 +10.1% $100.80
2025-10-31 Bernstein Lee Hambright $93 $98 +5 +7.5% $91.17
2025-10-15 Truist Financial $88 $103 +15 +8.1% $95.26
2025-10-10 RBC Capital $105 $111 +6 +16.0% $95.72
2025-08-26 Argus Research David Toung $165 $115 -50 +24.8% $92.18
2025-01-08 Bernstein Lee Hambright Initiated $93 +12.5% $82.68
2024-10-15 Robert W. Baird David Rescott $87 $96 +9 +6.7% $90.01
2024-10-10 RBC Capital Shagun Singh $92 $105 +13 +18.8% $88.35
2024-10-01 Evercore ISI Vijay Kumar Initiated $104 +15.5% $90.03
2024-10-01 Citigroup Joanne Wuensch $85 $92 +7 +2.2% $90.03
2024-08-21 Goldman Sachs David Roman Initiated $82 -5.1% $86.40
2024-08-21 Oppenheimer Steven Lichtman $85 $94 +9 +8.7% $86.46
2024-08-21 Piper Sandler Matt O'Brien $105 $90 -15 +5.4% $85.38
2024-08-21 Mizuho Securities Anthony Petrone Initiated $98 +13.5% $86.38
2024-08-21 Wells Fargo Larry Biegelsen $105 $106 +1 +24.2% $85.38
2024-08-20 Stifel Nicolaus Rick Wise $100 $87 -13 +1.9% $85.38
2024-05-24 Robert W. Baird David Rescott $90 $87 -3 +6.2% $81.91
2024-05-24 RBC Capital Shagun Singh $89 $92 +3 +13.0% $81.38
2024-05-24 Truist Financial Richard Newitter $97 $88 -9 +8.1% $81.38
2024-05-24 Wells Fargo Larry Biegelsen $77 $105 +28 +29.0% $81.38
2024-05-23 Stifel Nicolaus Rick Wise $105 $100 -5 +22.9% $81.38
2023-08-10 Robert W. Baird David Rescott Initiated $90 +8.5% $82.94
2023-01-09 RBC Capital $102 $89 -13 +10.1% $80.86
2022-11-30 Wells Fargo $96 $77 -19 +0.7% $76.49
2022-11-25 Barclays Initiated $85 +7.4% $79.12
2022-11-23 Morgan Stanley Cecilia Furlong $101 $88 -13 +12.1% $78.53
2022-11-23 Deutsche Bank Pito Chickering $85 $80 -5 +1.9% $78.53
2022-11-23 RBC Capital $110 $102 -8 +29.4% $78.84
2022-11-23 Oppenheimer Initiated $85 +9.0% $77.97
2022-11-23 Citigroup $117 $85 -32 +9.1% $77.93

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

A-
May 22, 2026
DCF
5
ROE
4
ROA
4
D/E
2
P/E
2
P/B
3
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. MDT receives an overall rating of A-. Strongest factors: DCF (5/5), ROE (4/5), ROA (4/5). Areas of concern: D/E (2/5), P/E (2/5).
Rating Change History
DateFromTo
2026-05-11 B+ A-
2026-05-04 B B+
2026-04-28 B+ B
2026-04-01 A- B+
2026-03-31 B+ A-
2026-03-23 A- B+
2026-03-20 B+ A-
2026-03-18 A- B+
2026-03-16 B+ A-
2026-03-13 A- B+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

57 Grade A
Profitability
55
Balance Sheet
67
Earnings Quality
76
Growth
51
Value
52
Momentum
80
Safety
65
Cash Flow
58
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. MDT scores highest in Momentum (80/100) and lowest in Growth (51/100). An overall grade of A places MDT among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
2.90
Grey Zone
Piotroski F-Score
6/9
Beneish M-Score
-2.51
Unlikely Manipulator
Ohlson O-Score
-9.32
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
A-
Score: 69.5/100
Trend: Deteriorating
Earnings Quality
100/100
OCF/NI: 1.49x
Accruals: -2.6%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. MDT scores 2.90, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. MDT scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. MDT's score of -2.51 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. MDT's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. MDT receives an estimated rating of A- (score: 69.5/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). MDT's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
21.84x
PEG
2.49x
P/S
2.84x
P/B
2.06x
P/FCF
23.17x
P/OCF
16.95x
EV/EBITDA
15.12x
EV/Revenue
4.03x
EV/EBIT
21.87x
EV/FCF
26.92x
Earnings Yield
3.95%
FCF Yield
4.32%
Shareholder Yield
3.78%
Graham Number
$55.73
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 21.8x earnings, MDT commands a growth premium. Graham's intrinsic value formula yields $55.73 per share, 41% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.836
NI / EBT
×
Interest Burden
0.889
EBT / EBIT
×
EBIT Margin
0.184
EBIT / Rev
×
Asset Turnover
0.383
Rev / Assets
×
Equity Multiplier
1.849
Assets / Equity
=
ROE
9.7%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. MDT's ROE of 9.7% is driven by Asset Turnover (0.383), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
4.49%
Fair P/E
17.48x
Intrinsic Value
$64.70
Price/Value
1.45x
Margin of Safety
-44.78%
Premium
44.78%
Assessment
Undervalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with MDT's realized 4.5% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. At an intrinsic value of $64.70, MDT appears undervalued with a -45% margin of safety. The adjusted fair P/E of 17.5x compares to the current market P/E of 21.8x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$78.58
Median 1Y
$76.71
5th Pctile
$50.88
95th Pctile
$115.88
Ann. Volatility
24.8%
Analyst Target
$105.57
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Geoffrey S. Martha
Chairman and Chief Executive Officer
$1,350,000 $12,625,000 $21,240,058
Sean M. Salmon
Former EVP & President, Cardiovascular Portfolio
$884,654 $4,537,157 $8,396,597
Brett A. Wall
EVP & President, Neuroscience Portfolio
$774,519 $4,537,157 $8,121,213
Gregory L. Smith
EVP Enterprise Operations
$894,560 $4,537,157 $8,083,981
Thierry Piéton Financial
Vice President and Chief Financial Officer
$138,517 $4,190,625 $5,212,448
Gary L. Corona
Former SVP Corporate Finance (former Interim CFO)
$466,346 $3,089,088 $3,795,248
Karen L. Parkhill
Former Executive Vice President and Chief Financial Officer
$262,856 $— $270,679

CEO Pay Ratio

186:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $21,240,058
Avg Employee Cost (SGA/emp): $114,200
Employees: 95,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
95,000
+171.4% YoY
Revenue / Employee
$353,021
Rev: $33,537,000,000
Profit / Employee
$49,074
NI: $4,662,000,000
SGA / Employee
$114,200
Avg labor cost proxy
R&D / Employee
$28,758
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 5.7% 7.1% 7.6% 9.2% 9.6% 9.7% 10.0% 8.3% 7.8% 7.2% 7.0% 7.9% 8.1% 7.2% 7.7% 8.4% 8.4% 9.5% 9.5% 9.7% 9.70%
ROA 3.2% 3.9% 4.2% 5.1% 5.3% 5.5% 5.7% 4.7% 4.4% 4.1% 4.0% 4.5% 4.6% 4.1% 4.3% 4.7% 4.7% 5.1% 5.1% 5.2% 5.25%
ROIC 5.7% 6.2% 6.6% 7.3% 7.6% 8.0% 8.3% 6.8% 6.4% 5.7% 5.5% 6.2% 6.4% 5.9% 6.2% 6.7% 6.8% 7.3% 7.5% 7.7% 7.73%
ROCE 4.3% 5.7% 6.0% 6.7% 7.1% 7.7% 8.0% 7.9% 7.6% 7.3% 7.5% 7.5% 7.6% 7.0% 7.1% 7.5% 7.6% 8.1% 8.1% 8.1% 8.13%
Gross Margin 66.3% 67.6% 67.5% 68.2% 68.3% 68.0% 65.9% 66.6% 65.2% 65.1% 65.9% 65.4% 65.6% 64.6% 65.1% 64.9% 66.5% 64.7% 57.7% 60.3% 60.32%
Operating Margin 16.4% 19.6% 10.8% 19.9% 21.4% 20.7% 15.3% 18.5% 18.0% 18.3% 16.5% 16.8% 18.3% 12.3% 16.1% 19.0% 19.9% 16.1% 16.8% 18.8% 18.80%
Net Margin 16.3% 16.6% 9.6% 16.7% 19.1% 18.4% 12.6% 5.6% 15.8% 13.8% 10.3% 11.4% 16.3% 7.6% 13.2% 15.1% 15.6% 11.8% 12.1% 15.3% 15.33%
EBITDA Margin 26.3% 29.2% 20.5% 29.4% 30.9% 30.1% 25.5% 28.8% 28.7% 28.3% 26.2% 27.1% 28.5% 19.9% 26.5% 29.1% 29.0% 25.5% 25.9% 26.4% 26.40%
FCF Margin 16.6% 16.2% 18.5% 18.2% 17.9% 18.9% 18.4% 15.7% 13.5% 14.7% 14.1% 12.7% 15.3% 16.1% 15.8% 16.7% 16.5% 15.5% 15.5% 15.0% 14.98%
OCF Margin 21.3% 20.7% 23.0% 22.5% 22.1% 23.2% 23.0% 20.4% 18.3% 19.3% 18.5% 17.4% 20.0% 21.0% 21.2% 21.8% 22.0% 21.0% 20.9% 20.5% 20.46%
ROE 3Y Avg snapshot only 8.81%
ROE 5Y Avg snapshot only 8.76%
ROA 3Y Avg snapshot only 4.82%
ROIC 3Y Avg snapshot only 6.10%
ROIC Economic snapshot only 6.89%
Cash ROA snapshot only 7.76%
Cash ROIC snapshot only 10.53%
CROIC snapshot only 7.70%
NOPAT Margin snapshot only 15.03%
Pretax Margin snapshot only 16.40%
R&D / Revenue snapshot only 8.17%
SGA / Revenue snapshot only 32.25%
SBC / Revenue snapshot only 1.31%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio 45.28 42.98 40.19 30.40 25.10 24.83 21.31 24.23 24.73 29.72 30.20 21.12 25.90 27.55 24.96 26.32 26.59 23.04 25.47 25.31 21.841
P/S Ratio 4.69 5.15 4.94 4.50 3.88 3.95 3.57 3.40 3.27 3.58 3.46 2.71 3.37 3.13 3.01 3.42 3.41 3.20 3.47 3.47 2.844
P/B Ratio 2.58 3.01 3.03 2.78 2.40 2.38 2.11 1.99 1.91 2.17 2.12 1.68 2.11 2.02 1.95 2.25 2.26 2.24 2.47 2.51 2.057
P/FCF 28.28 31.74 26.65 24.77 21.73 20.93 19.38 21.71 24.12 24.38 24.59 21.41 22.07 19.47 19.05 20.53 20.72 20.72 22.39 23.17 23.166
P/OCF 22.03 24.85 21.51 19.97 17.54 17.03 15.54 16.65 17.83 18.49 18.74 15.55 16.82 14.92 14.21 15.69 15.53 15.25 16.61 16.95 16.955
EV/EBITDA 23.47 22.68 22.17 18.93 15.91 15.80 13.81 13.30 13.08 14.73 14.22 11.68 14.06 14.42 13.89 15.17 15.06 13.78 14.79 15.12 15.120
EV/Revenue 5.18 5.66 5.43 4.99 4.37 4.38 4.01 3.84 3.71 4.10 3.98 3.22 3.87 3.65 3.53 3.94 3.93 3.79 4.04 4.03 4.032
EV/EBIT 41.61 35.39 34.08 27.97 23.03 22.84 19.73 19.10 18.98 21.34 20.48 16.84 20.09 21.30 20.38 21.94 21.79 19.98 21.61 21.87 21.871
EV/FCF 31.27 34.92 29.31 27.47 24.47 23.19 21.75 24.52 27.37 27.97 28.28 25.46 25.40 22.75 22.36 23.62 23.84 24.49 26.07 26.92 26.921
Earnings Yield 2.2% 2.3% 2.5% 3.3% 4.0% 4.0% 4.7% 4.1% 4.0% 3.4% 3.3% 4.7% 3.9% 3.6% 4.0% 3.8% 3.8% 4.3% 3.9% 4.0% 3.95%
FCF Yield 3.5% 3.2% 3.8% 4.0% 4.6% 4.8% 5.2% 4.6% 4.1% 4.1% 4.1% 4.7% 4.5% 5.1% 5.2% 4.9% 4.8% 4.8% 4.5% 4.3% 4.32%
PEG Ratio snapshot only 2.485
EV/OCF snapshot only 19.704
EV/Gross Profit snapshot only 6.475
Acquirers Multiple snapshot only 22.561
Shareholder Yield snapshot only 3.78%
Graham Number snapshot only $55.73
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 2.13 2.65 2.65 2.65 2.65 1.86 1.86 1.86 1.86 2.39 2.39 2.39 2.39 2.03 2.03 2.03 2.03 1.85 1.85 1.85 1.849
Quick Ratio 1.72 2.14 2.14 2.14 2.14 1.49 1.49 1.49 1.49 1.81 1.81 1.81 1.81 1.55 1.55 1.55 1.55 1.42 1.42 1.42 1.424
Debt/Equity 0.49 0.51 0.51 0.51 0.51 0.46 0.46 0.46 0.46 0.47 0.47 0.47 0.47 0.50 0.50 0.50 0.50 0.59 0.59 0.59 0.594
Net Debt/Equity 0.27 0.30 0.30 0.30 0.30 0.26 0.26 0.26 0.26 0.32 0.32 0.32 0.32 0.34 0.34 0.34 0.34 0.41 0.41 0.41 0.407
Debt/Assets 0.27 0.28 0.28 0.28 0.28 0.27 0.27 0.27 0.27 0.27 0.27 0.27 0.27 0.28 0.28 0.28 0.28 0.31 0.31 0.31 0.311
Debt/EBITDA 4.02 3.51 3.41 3.15 3.02 2.75 2.68 2.71 2.77 2.80 2.76 2.76 2.74 3.05 3.02 2.92 2.89 3.09 3.05 3.08 3.076
Net Debt/EBITDA 2.24 2.07 2.01 1.86 1.78 1.54 1.50 1.52 1.55 1.89 1.86 1.86 1.84 2.08 2.05 1.99 1.97 2.12 2.09 2.11 2.109
Interest Coverage 3.68 5.21 5.65 10.16 10.93 10.98 10.88 11.02 10.15 9.44 9.90 8.97 8.87 7.74 7.66 7.73 7.90 8.72 8.67 9.03 9.025
Equity Multiplier 1.79 1.81 1.81 1.81 1.81 1.73 1.73 1.73 1.73 1.77 1.77 1.77 1.77 1.79 1.79 1.79 1.79 1.91 1.91 1.91 1.909
Cash Ratio snapshot only 0.696
Debt Service Coverage snapshot only 13.055
Cash to Debt snapshot only 0.314
FCF to Debt snapshot only 0.183
Defensive Interval snapshot only 366.1 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.31 0.33 0.34 0.35 0.35 0.34 0.34 0.33 0.33 0.34 0.35 0.35 0.36 0.36 0.36 0.36 0.37 0.37 0.38 0.38 0.383
Inventory Turnover 2.53 2.45 2.48 2.43 2.39 2.27 2.25 2.26 2.31 2.16 2.19 2.23 2.25 2.13 2.16 2.19 2.19 2.18 2.34 2.45 2.453
Receivables Turnover 5.14 5.96 6.25 6.29 6.29 5.75 5.64 5.59 5.59 5.41 5.47 5.53 5.60 5.34 5.37 5.44 5.48 5.31 5.41 5.50 5.498
Payables Turnover 5.11 5.11 5.16 5.06 4.98 4.63 4.59 4.61 4.72 4.34 4.39 4.48 4.52 4.42 4.47 4.55 4.55 4.79 5.15 5.40 5.398
DSO 71 61 58 58 58 63 65 65 65 67 67 66 65 68 68 67 67 69 67 66 66.4 days
DIO 144 149 147 150 153 161 162 161 158 169 167 164 162 171 169 166 166 168 156 149 148.8 days
DPO 71 71 71 72 73 79 79 79 77 84 83 82 81 83 82 80 80 76 71 68 67.6 days
Cash Conversion Cycle 144 139 135 136 137 145 147 147 146 152 151 148 147 157 155 153 153 160 153 148 147.6 days
Fixed Asset Turnover snapshot only 5.084
Operating Cycle snapshot only 215.2 days
Cash Velocity snapshot only 3.877
Capital Intensity snapshot only 2.638
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue -10.1% 4.2% 13.1% 14.1% 13.8% 5.2% -1.7% -3.1% -3.2% -1.4% 1.6% 3.7% 5.0% 3.6% 3.2% 3.3% 2.7% 3.6% 5.0% 5.3% 5.34%
Net Income -45.6% -24.7% -12.0% 33.0% 70.0% 39.7% 34.0% -8.2% -17.3% -25.4% -30.5% -5.1% 3.4% -2.2% 8.5% 4.6% 1.4% 26.8% 18.7% 11.1% 11.12%
EPS -45.8% -25.2% -12.4% 32.7% 70.7% 41.1% 36.2% -6.6% -16.2% -24.8% -30.4% -5.1% 3.4% -1.6% 11.6% 8.2% 5.0% 30.6% 19.6% 11.1% 11.07%
FCF -30.5% -18.9% 23.1% 21.5% 22.6% 22.4% -2.3% -16.5% -26.6% -23.4% -22.3% -16.1% 18.4% 13.5% 15.8% 35.9% 10.9% -0.3% 3.1% -5.3% -5.33%
EBITDA -34.7% -3.7% 10.7% 28.4% 41.6% 16.7% 16.4% 6.1% -0.3% -0.9% -1.9% -0.8% 2.2% -5.7% -6.3% -2.9% -2.8% 12.4% 12.8% 8.3% 8.28%
Op. Income -50.2% -6.4% 17.4% 49.1% 77.9% 28.2% 28.8% 10.5% -1.7% -4.6% -6.5% -5.0% 1.1% -6.2% -8.4% -2.8% -1.5% 15.8% 18.8% 14.8% 14.85%
OCF Growth snapshot only -1.14%
Asset Growth snapshot only 1.89%
Equity Growth snapshot only -4.36%
Debt Growth snapshot only 13.95%
Shares Change snapshot only 0.05%
Dividend Growth snapshot only -0.30%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y -2.1% 0.2% 1.8% 1.5% 1.3% 1.2% 0.4% -0.1% -0.3% 2.6% 4.2% 4.7% 5.0% 2.4% 1.0% 1.2% 1.5% 1.9% 3.3% 4.1% 4.10%
Revenue 5Y -0.5% 0.9% 1.9% 1.9% 1.6% 1.3% 0.7% 0.8% 0.7% 0.8% 1.1% 1.0% 1.1% 1.2% 1.2% 1.3% 1.3% 3.0% 4.1% 4.5% 4.52%
EPS 3Y 0.9% 5.3% 7.3% 27.8% 0.0% 3.0% 6.1% -2.1% -8.1% -7.4% -6.0% 5.6% 13.9% 1.5% 1.9% -1.4% -3.1% -1.1% -2.4% 4.5% 4.49%
EPS 5Y 4.5% 1.2% 2.0% 2.6% 4.9% 5.1% 5.4% -2.5% 8.0% 4.4% 3.2% 13.1% -2.8% -4.2% -1.5% -0.7% -3.4% 0.4% 2.1% 7.2% 7.19%
Net Income 3Y 1.0% 5.1% 7.1% 27.7% -0.0% 2.9% 5.6% -2.5% -8.6% -7.8% -6.4% 5.1% 13.3% 0.6% 0.4% -3.0% -4.7% -2.6% -3.6% 3.3% 3.31%
Net Income 5Y 3.5% 0.4% 1.3% 2.1% 4.4% 4.6% 4.8% -2.9% 7.7% 3.9% 2.7% 12.6% -3.1% -4.5% -2.3% -1.7% -4.3% -0.5% 1.1% 6.1% 6.14%
EBITDA 3Y -9.5% -4.3% -3.6% -2.4% -2.2% -1.9% -1.6% -1.6% -2.7% 3.7% 8.1% 10.6% 13.0% 2.9% 2.3% 0.7% -0.3% 1.6% 1.2% 1.4% 1.40%
EBITDA 5Y -3.5% -2.5% -2.1% -0.7% 0.6% 0.4% 0.8% 1.3% 0.9% 0.3% 0.5% -0.4% -0.9% -2.5% -2.6% -1.7% -1.7% 3.4% 6.0% 7.3% 7.27%
Gross Profit 3Y -4.7% -2.0% -0.0% 0.1% 0.1% 0.2% -0.5% -1.1% -1.5% 1.7% 4.1% 5.1% 5.9% 2.5% 0.3% 0.1% 0.1% 0.6% 1.1% 1.5% 1.49%
Gross Profit 5Y -1.1% -0.1% 1.2% 1.5% 1.4% 1.1% 0.4% 0.2% -0.2% -0.4% -0.3% -0.5% -0.3% -0.2% -0.1% 0.1% 0.2% 2.4% 3.4% 3.8% 3.76%
Op. Income 3Y -20.4% -12.3% -10.4% -4.8% -3.1% -2.8% -2.6% -2.5% -4.5% 4.6% 12.3% 16.1% 21.0% 4.7% 3.3% 0.7% -0.7% 1.2% 0.6% 2.0% 1.97%
Op. Income 5Y -7.7% -3.3% -2.6% -0.4% 1.8% 1.5% 1.7% -0.7% -2.5% -3.8% -2.8% -2.0% -2.0% -3.9% -4.6% -3.1% -2.8% 4.4% 9.0% 11.8% 11.79%
FCF 3Y 2.4% 10.5% 8.6% 5.9% 5.3% 0.6% 0.3% -8.5% -14.5% -8.7% -2.2% -5.2% 2.1% 2.1% -4.2% -1.6% -1.3% -4.6% -2.5% 2.6% 2.59%
FCF 5Y -0.9% 3.2% 4.1% 3.1% 1.9% 1.2% 3.3% 2.2% -0.7% 4.8% -0.5% -3.6% 0.3% -2.4% -1.9% -2.7% -3.9% -2.9% 2.2% 1.8% 1.84%
OCF 3Y 3.1% 10.0% 8.7% 6.6% 5.7% 1.6% 1.6% -5.8% -10.5% -5.8% -1.0% -2.4% 2.9% 2.8% -1.7% 0.2% 1.2% -1.4% 0.0% 4.2% 4.18%
OCF 5Y 0.5% 3.6% 4.0% 3.1% 1.8% 1.3% 3.3% 2.7% 0.8% 5.2% 0.6% -1.2% 1.7% -0.6% 0.2% -0.9% -1.5% -0.5% 3.6% 3.5% 3.48%
Assets 3Y -3.1% 0.6% 0.6% 0.6% 0.6% 0.5% 0.5% 0.5% 0.5% 0.1% 0.1% 0.1% 0.1% -1.1% -1.1% -1.1% -1.1% 0.3% 0.3% 0.3% 0.26%
Assets 5Y -3.2% -1.3% -1.3% -1.3% -1.3% -1.8% -1.8% -1.8% -1.8% -0.1% -0.1% -0.1% -0.1% 0.1% 0.1% 0.1% 0.1% 0.2% 0.2% 0.2% 0.22%
Equity 3Y 0.3% 0.5% 0.5% 0.5% 0.5% 1.6% 1.6% 1.6% 1.6% 0.5% 0.5% 0.5% 0.5% -0.8% -0.8% -0.8% -0.8% -3.0% -3.0% -3.0% -2.96%
Book Value 3Y 0.2% 0.7% 0.7% 0.6% 0.5% 1.8% 2.1% 2.1% 2.1% 0.9% 0.9% 1.0% 1.1% 0.0% 0.7% 0.9% 0.8% -1.5% -1.8% -1.9% -1.85%
Dividend 3Y 2.5% 2.7% 2.9% 2.9% 2.8% 2.9% 3.0% 2.9% 2.8% 2.7% 2.2% 1.9% 1.6% 1.3% 1.7% 1.6% 1.1% 0.7% 0.8% 1.0% 1.04%
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.01 0.16 0.18 0.11 0.07 0.26 0.10 0.11 0.08 0.46 0.33 0.25 0.25 0.61 0.70 0.56 0.55 0.91 0.98 0.99 0.995
Earnings Stability 0.14 0.11 0.13 0.00 0.07 0.23 0.36 0.02 0.04 0.05 0.09 0.29 0.11 0.29 0.11 0.01 0.02 0.02 0.00 0.31 0.311
Margin Stability 0.96 0.97 0.97 0.97 0.96 0.97 0.98 0.97 0.97 0.97 0.97 0.97 0.96 0.97 0.97 0.97 0.98 0.98 0.98 0.97 0.973
Rev. Growth Consistency 0.00 0.50 0.50 0.50 0.50 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.50 0.00 0.50 0.50 1.00 0.50 1.00 1.00 1.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.82 0.90 0.95 0.87 0.50 0.84 0.86 0.97 0.93 0.90 0.88 0.98 0.99 0.99 0.97 0.98 0.99 0.89 0.93 0.96 0.956
Earnings Smoothness 0.41 0.72 0.87 0.72 0.48 0.67 0.71 0.91 0.81 0.71 0.64 0.95 0.97 0.98 0.92 0.96 0.99 0.76 0.83 0.89 0.895
ROE Trend -0.04 -0.02 -0.01 0.01 0.01 0.01 0.02 0.00 0.00 -0.01 -0.02 -0.01 -0.00 -0.01 -0.01 0.00 0.01 0.02 0.02 0.02 0.017
Gross Margin Trend -0.06 -0.04 -0.01 0.00 0.01 0.02 0.01 0.01 0.01 -0.01 -0.01 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 -0.00 -0.02 -0.03 -0.030
FCF Margin Trend -0.02 -0.04 0.01 -0.01 -0.01 0.00 0.01 -0.02 -0.04 -0.03 -0.04 -0.04 -0.00 -0.01 -0.00 0.03 0.02 0.00 0.01 0.00 0.003
Sustainable Growth Rate -0.3% 1.0% 1.4% 2.8% 3.1% 3.2% 3.4% 1.6% 1.0% 0.3% -0.0% 0.9% 1.0% 0.0% 0.6% 1.3% 1.3% 2.2% 2.2% 2.3% 2.34%
Internal Growth Rate 0.5% 0.8% 1.6% 1.8% 1.8% 2.0% 0.9% 0.6% 0.2% 0.5% 0.6% 0.0% 0.3% 0.7% 0.7% 1.2% 1.2% 1.3% 1.28%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 2.06 1.73 1.87 1.52 1.43 1.46 1.37 1.46 1.39 1.61 1.61 1.36 1.54 1.85 1.76 1.68 1.71 1.51 1.53 1.49 1.493
FCF/OCF 0.78 0.78 0.81 0.81 0.81 0.81 0.80 0.77 0.74 0.76 0.76 0.73 0.76 0.77 0.75 0.76 0.75 0.74 0.74 0.73 0.732
FCF/Net Income snapshot only 1.093
OCF/EBITDA snapshot only 0.767
CapEx/Revenue 4.7% 4.5% 4.4% 4.4% 4.3% 4.3% 4.6% 4.8% 4.8% 4.7% 4.4% 4.8% 4.8% 4.9% 5.4% 5.1% 5.5% 5.5% 5.4% 5.5% 5.49%
CapEx/Depreciation snapshot only 0.667
Accruals Ratio -0.03 -0.03 -0.04 -0.03 -0.02 -0.03 -0.02 -0.02 -0.02 -0.03 -0.02 -0.02 -0.02 -0.03 -0.03 -0.03 -0.03 -0.03 -0.03 -0.03 -0.026
Sloan Accruals snapshot only -0.034
Cash Flow Adequacy snapshot only 1.288
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 2.3% 2.0% 2.0% 2.3% 2.7% 2.7% 3.1% 3.3% 3.5% 3.2% 3.3% 4.2% 3.4% 3.6% 3.7% 3.2% 3.2% 3.3% 3.0% 3.0% 3.61%
Dividend/Share $2.26 $2.30 $2.35 $2.40 $2.46 $2.52 $2.58 $2.63 $2.67 $2.71 $2.72 $2.74 $2.75 $2.77 $2.81 $2.82 $2.80 $2.79 $2.80 $2.81 $2.84
Payout Ratio 1.1% 86.5% 82.1% 69.2% 67.6% 67.1% 66.1% 80.9% 87.5% 96.2% 1.0% 88.9% 87.1% 99.7% 92.8% 84.5% 84.6% 77.0% 77.3% 75.8% 75.84%
FCF Payout Ratio 66.1% 63.9% 54.5% 56.4% 58.5% 56.6% 60.1% 72.5% 85.3% 79.0% 81.7% 90.1% 74.2% 70.5% 70.9% 65.9% 65.9% 69.2% 67.9% 69.4% 69.42%
Total Payout Ratio 1.1% 1.0% 1.1% 97.4% 1.0% 1.2% 1.2% 1.3% 1.4% 1.1% 1.1% 1.0% 1.0% 1.6% 2.1% 1.9% 1.9% 1.5% 95.8% 95.8% 95.78%
Div. Increase Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0
Chowder Number 0.10 0.10 0.10 0.11 0.11 0.11 0.11 0.11 0.11 0.10 0.09 0.08 0.06 0.05 0.04 0.03 0.02 0.01 0.02 0.03 0.027
Buyback Yield 0.1% 0.4% 0.6% 0.9% 1.4% 2.0% 2.3% 2.2% 1.9% 0.6% 0.4% 0.6% 0.6% 2.1% 4.6% 4.0% 4.1% 3.0% 0.7% 0.8% 0.79%
Net Buyback Yield -0.1% 0.1% 0.3% 0.5% 1.0% 1.7% 2.0% 1.9% 1.7% 0.3% 0.1% 0.3% 0.3% 1.8% 4.3% 3.7% 3.6% 2.5% 0.3% 0.3% 0.35%
Total Shareholder Return 2.2% 2.1% 2.3% 2.8% 3.7% 4.4% 5.1% 5.2% 5.2% 3.5% 3.4% 4.5% 3.6% 5.5% 8.0% 6.9% 6.8% 5.9% 3.3% 3.3% 3.34%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.14 0.93 0.94 0.92 0.90 0.91 0.91 0.77 0.75 0.70 0.66 0.75 0.76 0.76 0.80 0.83 0.82 0.83 0.82 0.84 0.836
Interest Burden (EBT/EBIT) 0.73 0.81 0.82 0.90 0.91 0.91 0.91 0.91 0.90 0.89 0.90 0.89 0.89 0.87 0.87 0.87 0.87 0.89 0.88 0.89 0.889
EBIT Margin 0.12 0.16 0.16 0.18 0.19 0.19 0.20 0.20 0.20 0.19 0.19 0.19 0.19 0.17 0.17 0.18 0.18 0.19 0.19 0.18 0.184
Asset Turnover 0.31 0.33 0.34 0.35 0.35 0.34 0.34 0.33 0.33 0.34 0.35 0.35 0.36 0.36 0.36 0.36 0.37 0.37 0.38 0.38 0.383
Equity Multiplier 1.79 1.80 1.80 1.80 1.80 1.77 1.77 1.77 1.77 1.75 1.75 1.75 1.75 1.78 1.78 1.78 1.78 1.85 1.85 1.85 1.849
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $2.13 $2.66 $2.86 $3.47 $3.64 $3.75 $3.90 $3.24 $3.05 $2.82 $2.71 $3.08 $3.15 $2.77 $3.03 $3.33 $3.31 $3.62 $3.62 $3.70 $3.70
Book Value/Share $37.42 $37.86 $37.92 $37.95 $38.09 $39.07 $39.38 $39.45 $39.45 $38.63 $38.60 $38.65 $38.66 $37.89 $38.73 $39.02 $39.04 $37.29 $37.31 $37.30 $38.37
Tangible Book/Share $-6.02 $-6.09 $-6.10 $-6.10 $-6.13 $-2.64 $-2.66 $-2.66 $-2.66 $-3.59 $-3.59 $-3.59 $-3.59 $-3.02 $-3.08 $-3.11 $-3.11 $-4.18 $-4.18 $-4.18 $-4.18
Revenue/Share $20.60 $22.17 $23.29 $23.46 $23.54 $23.56 $23.28 $23.13 $23.10 $23.43 $23.66 $23.99 $24.27 $24.42 $25.13 $25.64 $25.81 $26.04 $26.57 $27.00 $27.68
FCF/Share $3.42 $3.60 $4.32 $4.26 $4.20 $4.44 $4.29 $3.62 $3.13 $3.44 $3.33 $3.04 $3.70 $3.92 $3.97 $4.27 $4.25 $4.03 $4.12 $4.04 $4.22
OCF/Share $4.38 $4.59 $5.35 $5.28 $5.21 $5.46 $5.35 $4.72 $4.23 $4.53 $4.37 $4.18 $4.86 $5.12 $5.32 $5.59 $5.67 $5.47 $5.55 $5.52 $5.68
Cash/Share $8.07 $7.96 $7.97 $7.98 $8.01 $7.86 $7.92 $7.94 $7.94 $5.97 $5.97 $5.98 $5.98 $6.04 $6.17 $6.22 $6.22 $6.96 $6.97 $6.96 $6.54
EBITDA/Share $4.55 $5.54 $5.71 $6.18 $6.47 $6.53 $6.75 $6.67 $6.54 $6.53 $6.63 $6.62 $6.69 $6.19 $6.39 $6.65 $6.73 $7.16 $7.26 $7.20 $7.20
Debt/Share $18.29 $19.43 $19.46 $19.47 $19.54 $17.93 $18.07 $18.10 $18.10 $18.28 $18.27 $18.29 $18.30 $18.88 $19.30 $19.45 $19.46 $22.14 $22.16 $22.15 $22.15
Net Debt/Share $10.21 $11.46 $11.48 $11.49 $11.53 $10.07 $10.15 $10.17 $10.17 $12.31 $12.30 $12.32 $12.32 $12.84 $13.13 $13.22 $13.23 $15.18 $15.19 $15.19 $15.19
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score 2.900
Altman Z-Prime snapshot only 5.288
Piotroski F-Score 4 7 7 8 9 7 5 4 4 5 7 6 8 5 6 6 7 8 7 6 6
Beneish M-Score -2.84 -2.42 -2.50 -2.46 -2.43 -2.60 -2.57 -2.57 -2.54 -2.49 -2.51 -2.46 -2.52 -2.64 -2.62 -2.61 -2.63 -2.54 -2.48 -2.51 -2.512
Ohlson O-Score snapshot only -9.317
Net-Net WC snapshot only $-15.23
EVA snapshot only $-1533054307.77
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only A-
Credit Score 66.82 74.17 74.75 80.70 76.25 79.25 73.98 74.78 72.60 73.03 72.61 72.99 73.63 73.07 72.38 74.02 73.84 69.26 69.74 69.47 69.466
Credit Grade snapshot only 7
Credit Trend snapshot only -4.557
Implied Spread (bps) snapshot only 175.000
Industry Credit Rank snapshot only 67
Sector Credit Rank snapshot only 67

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms